Showing results (1781-1790 of 2,048) with videos related to

Sort By:
Pageof 205
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
European Journal of Heart Failure|May 4, 2025
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Ovidiu Chioncel, Alexandre Mebazaa, Dimitrios Farmakis, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2020
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical controlRebecca G Levin-Epstein, Naomi Y Jiang, Xiaoyan Wang, et al.
Annals of the American Thoracic Society|June 4, 2020
Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19Jonathan D Casey, Nicholas J Johnson, Matthew W Semler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 15, 2020
Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patientsRebecca Levin-Epstein, Ryan R Cook, J Karen Wong, et al.
Contemporary Clinical Trials|May 28, 2025
Protocol for a pragmatic trial to enhance quality safety, and patient experience in chronic obstructive pulmonary disease (EQuiP-COPD)Lucas M Donovan, Laura C Feemster, Margaret P Collins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell LymphomaFranck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Arthritis Care & Research|September 11, 2023
Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis-Associated Lung DiseaseYannan Huang, Laura Sompii-Montgomery, Jessica Patti, et al.
Blood|October 13, 2023
The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphomaPietro R Di Ciaccio, Mark N Polizzotto, Kate Cwynarski, et al.
Hemasphere|February 26, 2026
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UKAndrea Kuhnl, Amy A Kirkwood, Michael Northend, et al.
Pageof 205